Study questions the value of intensive cardiac surveillance in cancer patients treated with anthracyclines

Дата публикации: 29-07-2026 19:20:04

A study led by investigators at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) suggests that intensive cardiac surveillance programs routinely used for lymphoma patients with low to moderate cardiovascular risk who are treated with anthracyclines may have limited clinical value.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	JACC: CardioOncology: Study questions the value of intensive cardiac surveillance in cancer patients treated with anthracyclines	0	7.82	28-07-2026
2	Cardiotoxicity of Immune Checkpoint Inhibitors	0	8	01-10-2024
3	Kidney cancer drug could slash the risk of repeated heart attacks in a similar way to statins, study suggests	0	8.9	01-09-2024
4	AI can accurately detect left ventricular dysfunction from electrocardiograms	0	8	31-07-2026
5	Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease	0	8.74	28-07-2026
6	No Difference in DFS Between Post-adjuvant Chemotherapy and Placebo In High-Risk Patients Identified Through ctDNA-based MRD Assessment After CRC Resection	0	5	22-06-2026
7	دراسات: أدوية إنقاص الوزن تقلل خطر الإصابة بسرطان الثدي	0	7	02-06-2026
8	Does giving chemotherapy before surgery improve survival and quality of life in women with advanced epithelial ovarian cancer?	0	4.1	01-01-1970
9	Exosome treatment may curb heart scarring after heart attacks	0	6.36	30-07-2026
10	Link between liver fibrosis in MASLD, ASCVD varies by glycemic status	0	6.8	01-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.46. Источник: medicalxpress.com.